Dynamic changes of interleukin 2 (IL-2) and circulating tumor cells (CTCs) in patients with advanced breast cancer (BCa) after systemic therapies.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.1090
Abstract: 1090Background: CTCs play a critical role in BCa metastasis and worse prognosis even after systemic treatments such as chemotherapy and biological therapy. The mechanisms that contribute to CTCs migration and tumor aggressiveness remain unknown. Herein,… read more here.
Keywords: systemic therapies; changes interleukin; bca; interleukin circulating ... See more keywords